Details of the Drug

General Information of Drug (ID: DMEFUSJ)

Drug Name
RG6296
Synonyms AFM-26
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DC3Y7O

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
B-cell maturation protein (TNFRSF17) TTZ3P4W TNR17_HUMAN Inhibitor [2]
Immunoglobulin gamma Fc receptor IIIA (FCGR3A) TTIFOC0 FCG3A_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04434469) A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Genentech.